This pragmatic clinical trial will (1) assess treatment retention and treatment outcomes at the completion of interdisciplinary intensive outpatient program (IOP) and at a 6-month follow-up comparing service members and veterans (SM/Vs) with mild traumatic brain injury (mTBI) + substance use (SU) and a TBI -control group; and (2) assess SU-related outcomes at the end of IOP treatment and durability of SU outcomes at 6-months follow-up among SM/Vs with co-occurring SU. Analyses of these key treatment outcomes along with input from lived experience consultants and other key stakeholders, will be used to refine and disseminate a scalable approach to treating individuals with mTBI and co-occurring SU.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
At least 18 years of age
US military service member or veteran
Diagnosis of mild traumatic brain injury (mTBI) and/or repetitive head impact/blast exposures
Participating in the SHARE Military Initiative intensive outpatient program
You may not be if
History of brain injury other than mTBI or progressive neurological disorder
Active psychosis
Not able to provide consent
Clareo Health | Expanding Access to mTBI Treatment for Veterans and Service Members With Co-occurring Substance Use
